Beyond the Headlines: How India’s PLI Scheme is Rewiring Its Manufacturing DNA
India’s PLI scheme has demonstrably accelerated manufacturing growth since 2021, with 806 approved projects driving over $20 billion in investment by mid-2025. The initiative generated 1.2 million jobs while boosting production across 14 strategic sectors to $190 billion. Transformative shifts emerged in key industries: electronics manufacturing surged 146%, with mobile exports exploding eightfold to $23 billion annually. Pharmaceuticals achieved a landmark reversal – transitioning from net importer to net exporter of essential bulk drugs within three years.
Though textiles grew steadily ($6B MMF exports), it faces stiff global competition. Rigorous performance tracking ensured $2.4 billion incentives were disbursed only after verified output milestones. With continued funding in FY2025-26, PLI has moved beyond pilot stage to establish foundational momentum for India’s “Make in India for the World” industrial vision.

India’s ambitious Production Linked Incentive (PLI) scheme, launched in 2021 with a hefty ₹1.97 trillion (US$22.8 billion) commitment, is demonstrably moving beyond policy promise into tangible economic transformation. The latest figures, current as of July 2025, paint a picture of accelerating momentum, with 806 projects approved across 14 strategic sectors, catalyzing over US$20.3 billion in realized investment and generating significant production, exports, and jobs.
More Than Just Numbers: Strategic Shifts Unfolding
While the headline figures are impressive, the real story lies in the structural shifts the PLI is driving within key industries:
- Electronics: From Assembly to Export Powerhouse: The flagship electronics segment, particularly mobile manufacturing, has seen explosive growth. Production value has surged 146% from FY 2020-21 (₹2.13 trillion / US$24.6bn) to FY 2024-25 (₹5.25 trillion / US$60.7bn). More crucially, exports have skyrocketed nearly eightfold, jumping from ₹228.7 billion (US$2.6bn) to ₹2 trillion (US$23.1bn) in the same period. This isn’t just import substitution; it’s India actively capturing global market share.
- Pharmaceuticals: Achieving Critical Self-Reliance: Perhaps the most striking turnaround is in pharma. Once a net importer of essential bulk drugs (APIs) to the tune of ₹19.3 billion (US$223m) in FY 2021-22, the sector leveraged the PLI to become a net exporter by FY 2024-25, recording exports worth ₹22.8 billion (US$264m). Total pharma sales under the scheme exceeded ₹2.66 trillion (US$30.7bn) in three years, including exports of ₹1.7 trillion (US$19.6bn). This strategic shift enhances India’s drug security and global standing.
- Textiles: Steady Gains Amidst Global Competition: While growth hasn’t been as meteoric as electronics, textiles show positive, steady progress. Man-Made Fiber (MMF) exports reached US$6 billion in FY 2024-25, up from US$5.7 billion the previous year. Technical textiles also rose to US$3.36 billion from US$2.99 billion. Acknowledging the challenge from cost-competitive neighbors like Bangladesh and Vietnam is crucial context, highlighting that sustained growth requires ongoing innovation and efficiency gains.
The Engine of Growth: Investment, Jobs, and Disciplined Incentives
- Investment Catalyst: The scheme has demonstrably unlocked private capital, with ₹1.76 trillion (US$20.3bn) invested by March 2025. This investment directly fueled production and sales output worth ₹16.5 trillion (US$190.9bn).
- Job Creation Powerhouse: Beyond balance sheets, the PLI impact is felt in livelihoods. Over 1.2 million direct and indirect jobs have been generated across the participating sectors, providing a significant socio-economic boost.
- Performance-Linked Discipline: The government has disbursed ₹215.34 billion (US$2.4 billion) in incentives until June 2025. Crucially, this payout is rigorously tied to verified companies meeting specific investment and production milestones, ensuring taxpayer money drives real results.
Looking Ahead: Sustained Commitment and Evolving Challenges
The Union Budget for FY 2025-26 reaffirms the commitment, earmarking significant funding:
- Electronics & IT Hardware: US$1.04 billion
- Automobiles & Components: US$326.2 million
- Textiles: US$132.8 million
- Pharmaceuticals: US$28.3 million
- Other Sectors (White Goods, Specialty Steel, Batteries): Continued support
The Verdict: A Foundation Laid, Building Upwards
India’s PLI scheme has unequivocally moved past its pilot phase. It has successfully attracted substantial investment, generated significant employment, and catalyzed demonstrable shifts in key sectors – particularly the remarkable turnarounds in electronics exports and pharmaceutical API self-sufficiency. While challenges like global competition in textiles persist, the scheme has laid a robust foundation for India’s “Make in India for the World” ambition. The sustained budgetary support signals a long-term vision.
The focus now must shift to ensuring these gains translate into deep-rooted industrial capability, continued innovation, and global competitiveness that endures beyond the incentive period. The PLI has ignited the engine; the journey towards becoming a global manufacturing hub is firmly underway.
You must be logged in to post a comment.